Visual prosthetic device developer VisionCare announced today that Thomas Ruggia has been appointed as its new CEO, effective today. Saratoga, Calif.-based VisionCare’s previous CEO and executive chairman of the board, Wolfgang Tolle, left the company to focus on new opportunities, according to a news release. “We’re thrilled to welcome Tom to VisionCare,” VisionCare CEO Richard […]
VisionCare Ophthalmic Technologies
VisionCare, Inc. said this week that the FDA approved its investigational device exemption for a new clinical trial in the U.S. evaluating its telescope implant in patients with end-stage macular degeneration. The Saratoga, Calif.-based company’s implantable miniature telescope, which was developed by Israeli inventor Dr. Isaac Lipshitz, is contraindicated for patients with previous intraocular or […]
Venture capital firm New Enterprise Associates said today it picked up ex-Medtronic (NYSE:MDT) executive veep Dr. Stephen Oesterle as a venture partner for the firm. Prior to being an executive veep for the medical giant, Oesterle served as senior veep of medicine and technology, and served as a member of the executive committee for 14 years, […]
Breast reconstruction technology company AirXpanders Inc. closed a $10 million Series D funding round to support its tissue expansion devices for breast reconstruction.
The Palo Alto, Calif.-based company plans to use the proceeds to advance investigational device exemptions studies, obtain CE Mark approval in Europe and execute market launches in the U.S., Europe and Australia following clearance of its AeroForm system.
After nearly a year, Sonova Holding AG (SIX:SOON) subsidary Advanced Bionics was allowed back in the U.S. market with its HiRes 90K cochlear implant.
In the past few months, Advanced Bionics received approval to resume distribution in Canada and countries accepting the CE Mark.
Approval of device pass-through payment allows eligible Medicare beneficiaries new AMD treatment option access
SARATOGA, Calif., Sept. 8, 2011 /PRNewswire/ — VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced that the Centers for Medicare and Medicaid Services (CMS) has granted transitional pass-through payment status and established a billing code for the Implantable Miniature Telescope (IMT™ by Dr. Isaac Lipshitz) under the Hospital Outpatient Prospective Payment System. The new pass-through code, C1840, is effective October 1, 2011 and will enable outpatient facilities to obtain reimbursement for the telescope implant for covered procedures.